Please use this identifier to cite or link to this item: http://hdl.handle.net/10321/1403
DC FieldValueLanguage
dc.contributor.authorVenugopala, Katharigatta Narayanaswamy-
dc.contributor.authorGovender, Reshme-
dc.contributor.authorKhedr, Mohammed A.-
dc.contributor.authorVenugopala, Rashmi-
dc.contributor.authorAldhubiab, Bandar E.-
dc.contributor.authorHarsha, Sree-
dc.contributor.authorOdhav, Bharti-
dc.date.accessioned2015-11-13T05:41:38Z-
dc.date.available2015-11-13T05:41:38Z-
dc.date.issued2015-02-15-
dc.identifier.citationVenugopala, K. N.; Govender, R.; Khedr, M. A.; Venugopala, R.; Aldhubiab, B. E.; Harsha, S. and Odhav, B. 2015. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents. Drug Design, Development and Therapy. 9 : 911-921.en_US
dc.identifier.issn1177-8881-
dc.identifier.urihttp://hdl.handle.net/10321/1403-
dc.description.abstractDihydropyrimidine scaffold has a wide range of potential pharmacological activi-ties such as antiviral, antitubercular, antimalarial, anti-inflammatory, and anticancer properties. 5-Lipoxygenase enzyme is an enzyme responsible for the metabolism of arachidonic acid to leukotrienes. The elevated levels of this enzyme and its metabolites in cancer cells have a direct relation on the development of cancer when compared to normal cells. The development of novel lipoxygenase inhibitors can have a major role in cancer therapy. A series of substituted 1,4-dihydropyrimidine analogues were synthesized and characterized by 1H-NMR, 13C-NMR, and HRMS. Molecular docking against lipoxygenase enzyme (protein data bank code =3V99) was done using Molecular Operating Environment 2013.08 and Leadit 2.1.2 softwares and showed high affinities. The synthesized compounds were tested for their lipoxygenase inhibitory activity and showed inhibition ranging from 59.37%±0.66% to 81.19%±0.94%. The activity was explained by a molecular docking study. The title compounds were also tested for cyto-toxic activity against two human cancer cell lines Michigan Cancer Foundation-7 and human melanoma cells and a normal peripheral blood mononuclear cell line.en_US
dc.format.extent11 pen_US
dc.language.isoenen_US
dc.publisherDove Pressen_US
dc.relation.ispartofDrug design, development and therapy-
dc.subject4-dihydropyrimidinesen_US
dc.subjectSynthesis and characterizationen_US
dc.subjectMolecular docking studyen_US
dc.titleDesign, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agentsen_US
dc.typeArticleen_US
dc.dut-rims.pubnumDUT-004843en_US
item.fulltextWith Fulltext-
item.languageiso639-1other-
item.grantfulltextopen-
Appears in Collections:Research Publications (Applied Sciences)
Files in This Item:
File Description SizeFormat
dhpm_anticancer_and_lipoxygenase_2015.pdf2.43 MBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

364
checked on Aug 9, 2020

Download(s) 50

447
checked on Aug 9, 2020

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.